Is serum cystatin C a better marker of kidney function than serum creatinine in septic newborns?

Journal Title: Advances in Hygiene and Experimental Medicine - Year 2012, Vol 66, Issue 0

Abstract

[sub][/sub] Introduction: Several studies have claimed that the estimation of serum cystatin C could be a better marker of kidney excretory function than serum creatinine. However, its role in the diagnosis of reduced kidney function was not unquestionably confirmed. The aim of this study was to analyze the concentrations of serum cystatin C in neonates with sepsis. Material/Methods: Thirty-two neonates (gestational age from 34 to 40 weeks) admitted to the NICU during the first 14 days of life were enrolled. Serum cystatin C concentrations were estimated by ELISA during three successive days in neonates treated for infection. The study group consisted of 9 newborns with sepsis, 14 with severe sepsis and 9 with septic shock. Results/Discussion: At the beginning of the observational period the mean serum concentration of cystatin C in the study group was 1.35 mg/L (95% CI 1.20–1.49). Surprisingly, the lowest concentration of cystatin was observed in patients with septic shock (1.23 mg/L; 95%CI 0.92–1.54) within the observation period. Higher concentrations were found in neonates with sepsis (1.47 mg/L; 95%CI 1.04–1.90) and severe sepsis (1.50; 1.12–1.87). There was no correlation between serum cystatin C concentration and serum creatinine or gestational age. A significant correlation was discovered between chronological age and cystatin C (R=–0.439, p=0.01). There was a tendency for cystatin C to decline during the second observational day in patients with sepsis (to 1.53 mg/L; 95%CI: 1.19–1.86) and severe sepsis (to 1.32 mg/L; 95%CI: 1.07–1.57), while a slight insignificant increase in patient with septic shock (to 1.28 mg/L; 95%CI: 0.88–1.68) was revealed. The interrelation between age and cystatin C concentration disappeared in the following days of stay in the NICU. Even in patients who died in the course of septic shock the observed changes in cystatin C levels were small and did not exceed those of serum creatinine. Conclusions: Cystatin C is not a useful marker of kidney function in neonates with sepsis.

Authors and Affiliations

Iwona Maruniak-Chudek, Teresa Owsianka-Podleśny, Jolanta Wróblewska, Danuta Jadamus-Niebrój

Keywords

Related Articles

Rola biosymilarów w reumatologii i innych dziedzinach medycyny

Biosymilary to nowe wersje innowacyjnych leków o wykazanym znacznym podobieństwie do produktu oryginalnego. Możliwe jest wystąpienie niewielkich różnic w klinicznie nieaktywnych komponentach cząsteczki, które mogą być is...

Autoantibodies in systemic sclerosis

Systemic sclerosis (SSc) is a rare connective tissue disorder, which leads to progressive fibrosis of many organs. Its course is characterized by the presence of two classical autoantibodies: anti-topoisomerase I (ATA, S...

Herpesviruses survival strategies – latency and apoptosis

Apoptosis is a process of programmed cell death in response to various stimuli, including virus infection. Herpesviruses have evolved the ability to interfere with apoptosis by its inhibition or activation in host cells....

Negatywna regulacja sygnalizacji receptorów Toll-podobnych

Mechanizm odporności wrodzonej działa w oparciu o receptory PRR – rozpoznające tzw. wzorce molekularne związane z patogenami – PAMPs. Wśród receptorów PRR wyróżnia się: receptory Toll-podobne (TLR). W wyniku kontaktu z p...

Depresja i proces zapalny w chorobach reumatologicznych

Badania wykazują, iż odsetek osób cierpiących na zaburzenie depresyjne wśród pacjentów z rozpoznaniem choroby reumatologicznej jest wyższy, niż procent osób z depresją w populacji ogólnej. Czynniki socjoekonomiczne nie s...

Download PDF file
  • EP ID EP66666
  • DOI -
  • Views 174
  • Downloads 0

How To Cite

Iwona Maruniak-Chudek, Teresa Owsianka-Podleśny, Jolanta Wróblewska, Danuta Jadamus-Niebrój (2012). Is serum cystatin C a better marker of kidney function than serum creatinine in septic newborns?. Advances in Hygiene and Experimental Medicine, 66(0), 175-180. https://europub.co.uk./articles/-A-66666